nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CYP3A5—Thalidomide—leprosy	0.224	0.289	CbGbCtD
Nimodipine—CYP3A5—Rifampicin—leprosy	0.217	0.28	CbGbCtD
Nimodipine—CYP3A5—Dapsone—leprosy	0.179	0.231	CbGbCtD
Nimodipine—CYP3A4—Rifampicin—leprosy	0.0845	0.109	CbGbCtD
Nimodipine—CYP3A4—Dapsone—leprosy	0.0698	0.0902	CbGbCtD
Nimodipine—CACNA1S—pes—leprosy	0.0649	0.391	CbGeAlD
Nimodipine—CACNA1D—ear—leprosy	0.015	0.0902	CbGeAlD
Nimodipine—CACNA1F—eye—leprosy	0.0133	0.0802	CbGeAlD
Nimodipine—CACNB4—tendon—leprosy	0.00581	0.0349	CbGeAlD
Nimodipine—CACNA1S—tendon—leprosy	0.00497	0.0299	CbGeAlD
Nimodipine—CACNB4—testis—leprosy	0.00481	0.0289	CbGeAlD
Nimodipine—CACNB4—nervous system—leprosy	0.00472	0.0284	CbGeAlD
Nimodipine—CACNB1—tendon—leprosy	0.00464	0.0279	CbGeAlD
Nimodipine—CACNB3—tendon—leprosy	0.00445	0.0268	CbGeAlD
Nimodipine—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.00432	0.0719	CcSEcCtD
Nimodipine—CACNB1—testis—leprosy	0.00384	0.0231	CbGeAlD
Nimodipine—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.0038	0.0634	CcSEcCtD
Nimodipine—CACNB1—nervous system—leprosy	0.00377	0.0227	CbGeAlD
Nimodipine—Platelet count decreased—Thalidomide—leprosy	0.00372	0.0619	CcSEcCtD
Nimodipine—CACNB3—testis—leprosy	0.00368	0.0222	CbGeAlD
Nimodipine—Deep vein thrombosis—Thalidomide—leprosy	0.00363	0.0605	CcSEcCtD
Nimodipine—CACNB3—nervous system—leprosy	0.00362	0.0217	CbGeAlD
Nimodipine—AHR—tendon—leprosy	0.0033	0.0198	CbGeAlD
Nimodipine—CACNB2—tendon—leprosy	0.00299	0.018	CbGeAlD
Nimodipine—AHR—testis—leprosy	0.00273	0.0164	CbGeAlD
Nimodipine—Acne—Thalidomide—leprosy	0.00263	0.0438	CcSEcCtD
Nimodipine—CACNB2—testis—leprosy	0.00248	0.0149	CbGeAlD
Nimodipine—CACNB2—nervous system—leprosy	0.00243	0.0146	CbGeAlD
Nimodipine—Phosphatase alkaline increased—Thalidomide—leprosy	0.00221	0.0368	CcSEcCtD
Nimodipine—NR3C2—tendon—leprosy	0.0022	0.0132	CbGeAlD
Nimodipine—CACNA1D—testis—leprosy	0.00216	0.013	CbGeAlD
Nimodipine—CACNA1D—nervous system—leprosy	0.00212	0.0128	CbGeAlD
Nimodipine—CACNA1C—testis—leprosy	0.002	0.012	CbGeAlD
Nimodipine—Lightheadedness—Thalidomide—leprosy	0.00198	0.0329	CcSEcCtD
Nimodipine—CACNA1C—nervous system—leprosy	0.00196	0.0118	CbGeAlD
Nimodipine—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00184	0.0307	CcSEcCtD
Nimodipine—NR3C2—testis—leprosy	0.00182	0.0109	CbGeAlD
Nimodipine—NR3C2—nervous system—leprosy	0.00178	0.0107	CbGeAlD
Nimodipine—Cardiac failure congestive—Thalidomide—leprosy	0.00177	0.0295	CcSEcCtD
Nimodipine—Hyponatraemia—Thalidomide—leprosy	0.00161	0.0268	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.0016	0.0267	CcSEcCtD
Nimodipine—Tachycardia—Dapsone—leprosy	0.0015	0.025	CcSEcCtD
Nimodipine—Liver function test abnormal—Thalidomide—leprosy	0.00148	0.0247	CcSEcCtD
Nimodipine—Cramp muscle—Thalidomide—leprosy	0.00145	0.0241	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Thalidomide—leprosy	0.00142	0.0236	CcSEcCtD
Nimodipine—Depression—Thalidomide—leprosy	0.00123	0.0205	CcSEcCtD
Nimodipine—Bradycardia—Thalidomide—leprosy	0.00113	0.0188	CcSEcCtD
Nimodipine—Hepatitis—Thalidomide—leprosy	0.00111	0.0185	CcSEcCtD
Nimodipine—Cardiac disorder—Thalidomide—leprosy	0.00103	0.0172	CcSEcCtD
Nimodipine—Angiopathy—Thalidomide—leprosy	0.00101	0.0168	CcSEcCtD
Nimodipine—Immune system disorder—Thalidomide—leprosy	0.001	0.0167	CcSEcCtD
Nimodipine—Vomiting—Dapsone—leprosy	0.00098	0.0163	CcSEcCtD
Nimodipine—Headache—Dapsone—leprosy	0.000965	0.0161	CcSEcCtD
Nimodipine—Muscle spasms—Thalidomide—leprosy	0.000929	0.0155	CcSEcCtD
Nimodipine—Nausea—Dapsone—leprosy	0.000915	0.0152	CcSEcCtD
Nimodipine—Anaemia—Thalidomide—leprosy	0.000893	0.0149	CcSEcCtD
Nimodipine—Palpitations—Thalidomide—leprosy	0.000854	0.0142	CcSEcCtD
Nimodipine—Hypertension—Thalidomide—leprosy	0.000834	0.0139	CcSEcCtD
Nimodipine—Myalgia—Thalidomide—leprosy	0.000823	0.0137	CcSEcCtD
Nimodipine—Oedema—Thalidomide—leprosy	0.000789	0.0131	CcSEcCtD
Nimodipine—Nervous system disorder—Thalidomide—leprosy	0.000773	0.0129	CcSEcCtD
Nimodipine—Thrombocytopenia—Thalidomide—leprosy	0.000772	0.0129	CcSEcCtD
Nimodipine—Tachycardia—Thalidomide—leprosy	0.00077	0.0128	CcSEcCtD
Nimodipine—Hyperhidrosis—Thalidomide—leprosy	0.000762	0.0127	CcSEcCtD
Nimodipine—Hypotension—Thalidomide—leprosy	0.000737	0.0123	CcSEcCtD
Nimodipine—CYP3A4—nervous system—leprosy	0.000724	0.00435	CbGeAlD
Nimodipine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000719	0.012	CcSEcCtD
Nimodipine—Dyspnoea—Thalidomide—leprosy	0.000703	0.0117	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Thalidomide—leprosy	0.000681	0.0113	CcSEcCtD
Nimodipine—Hypersensitivity—Thalidomide—leprosy	0.000581	0.00968	CcSEcCtD
Nimodipine—Pruritus—Thalidomide—leprosy	0.000558	0.00929	CcSEcCtD
Nimodipine—Diarrhoea—Thalidomide—leprosy	0.00054	0.00899	CcSEcCtD
Nimodipine—Dizziness—Thalidomide—leprosy	0.000522	0.00869	CcSEcCtD
Nimodipine—Vomiting—Thalidomide—leprosy	0.000501	0.00835	CcSEcCtD
Nimodipine—Rash—Thalidomide—leprosy	0.000497	0.00828	CcSEcCtD
Nimodipine—Dermatitis—Thalidomide—leprosy	0.000497	0.00827	CcSEcCtD
Nimodipine—Headache—Thalidomide—leprosy	0.000494	0.00823	CcSEcCtD
Nimodipine—Nausea—Thalidomide—leprosy	0.000468	0.0078	CcSEcCtD
